Success Stories: Our Firm Efficiently Helped a Chinese Postdoctoral Fellow in the Field of Molecular Biology Attain an EB-1A Petition Approval (PP Without RFE)

Client’s Testimonial:

“I’m very excited to hear this news. It won’t be possible without your expertise and hard working. Thank you very much.”

On April 28^th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: California

Approval Notice Date: April 28^th, 2016

Processing Time: 4 Days (Premium Processing Requested)

Case Summary:

Merely 3 days after we filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of a postdoctoral fellow working in the field of molecular biology, we received notification of case approval.

The Perks of Premium Processing:

The reason for such quick processing is due to Premium Processing (PP), which means that the USCIS will take action on these cases within 15 days. Petitioners who opt for PP do not have to wait 4-9 months for their cases to be processed, allowing them to save plenty of time in the overall green card journey. To qualify for PP, one’s case must be filed under specific EB-1, EB-2 and EB-3 visa categories and fortunately for our client, EB-1A is one of them. By paying an additional $1,225 and submitting an I-907 form to the USCIS, he got to enjoy rapid adjudication, which is a great option for those who are unwilling or unable to wait several months for action to be taken on their case.

Laying a Solid Foundation:

Although the team at North America Immigration Law Group (WeGreened.com) is extremely skilled at putting together strong EB-1A petitions, our clients’ credentials are the basis for a strong case. In this instance, we noted our client’s Ph.D. in Biochemistry and Molecular Biology to prove that he has the knowledge needed to carry out influential research that benefits the United States. We also listed the 269 citations gathered from his 5 published scientific articles and the 20 times he assessed the work of his peers.

To ensure that our client’s EB-1A case was as solid as could be, we included the six recommendation letters that he had gathered from independent and dependent experts in the field of molecular biology, all of whom are prominent professors. According to one of them: “The sustained success that [Client] has experienced in his career provides a certain guarantee that he will maintain his position at the top of his field for the foreseeable future. His background in molecular biology and significant research experience have allowed him to become one of the most distinguished researchers in his discipline today.” We also documented his research on molecular medicine that is applied in treating blood disorders, heart diseases, and musculoskeletal disorders. By proving that our client is an asset to the nation and that his findings are important to the U.S., most notably its medical sector, the USCIS was swayed to approve his EB-1A petition.

Seeing that our client now has an approved EB-1A petition, he is free to adjust his status for permanent residence without waiting several years for his priority date to become current. He is doing this by filing an I-485 application with the help of our comprehensive D.I.Y. Packet. We wish him the best with this and hope that the USCIS approves his application, enabling him to obtain his green card.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.